Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-217622 Compared With Placebo in Non-Hospitalized Participants With COVID-19
NCT05305547Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2022
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of ensitrelvir in coronavirus disease 2019 (COVID-19), sponsored by Shionogi & Co., Ltd.. Started Aug 2022; status: completed.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05305547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05305547.